Search
Search Results
-
PET/CT in Breast Cancer
The aim of this book is to provide crisp information related to pathology, management and radiological/molecular imaging in breast carcinoma, along...
-
PET receptor imaging in breast cancer
Most of the breast cancers overexpress certain receptors which have a role in development and progression of the disease. Receptors are also target...
-
Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer
PurposeBreast cancer is the most common malignancy accounting for 11.7% of all cancer cases, with a rising incidence rate. Various diagnostic...
-
Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer
PurposeHuman epidermal growth factor receptor 2 (HER2)-positive breast cancer cases are among the most aggressive breast tumor subtypes. Accurately...
-
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
ObjectivesTo investigate the diagnostic feasibility of a shortened breast PET/MRI protocol in breast cancer patients.
MethodsAltogether 90 women...
-
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature
To provide an overview of the current available data about FAPI PET in breast cancer patients, with a perspective point of view. A literature search...
-
Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer — a retrospective comparative study with PET/CT and breast MRI
BackgroundSentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in early breast cancer patients with low-burden axillary...
-
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer
PurposeBreast cancer (BC) patients undergoing FDG-PET/CT scans for neoadjuvant chemotherapy (NAC) may have additional non-BC related findings. The...
-
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound
ObjectiveTo compare the diagnostic performance of dedicated breast positron emission tomography (dbPET) in breast cancer screening with digital...
-
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI
PurposeTo evaluate if a machine learning prediction model based on clinical and easily assessable imaging features derived from baseline breast [ 18 F]...
-
Physiological Uptake Characteristics of Breast on 68Ga-FAPI-04 PET/CT
PurposeGallium 68 ( 68 Ga)-labeled fibroblast activation protein inhibitor (FAPI) PET/CT is sensitive on breast cancer staging, but its clinical...
-
Exploration of tumor size measurement methods in preoperative breast cancer assessment using whole-body silicon photomultiplier PET: feasibility and first results
PurposeWhole-body silicon photomultiplier positron emission tomography (WB SiPM PET) could be used to diagnose breast cancer spread before...
-
Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
PurposeVarious treatment options are available for breast cancer in the neoadjuvant and in the metastatic setting. Early and accurate assessment can...
-
Prognostic impact of 18F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer
BackgroundThe aim of this study is to investigate the impact of 18 F-FDG PET/CT on prognosis of stage II invasive ductal carcinoma (IDC) of the...
-
Association Between 18F-FDG PET Activity and HER2 Status in Breast Cancer Brain Metastases
PurposeThe objective of this study was to evaluate whether uptake on 18 F-fluorodeoxyglucose ( 18 F-FDG) PET could help differentiate HER2-positive...
-
PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry
ObjectivesTo explore the relationship between indices of hypoxia and vascular function from 18 F-fluoromisonidazole ([ 18 F]-FMISO)-PET/MRI with...
-
Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors
Background and purposePerfusion parameters obtained in F-18 FDG PET/CT performed for staging purposes in breast cancers may provide additional...
-
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy
PurposeTo verify the ability of pretreatment [ 18 F]FDG PET/CT and T1-weighed dynamic contrast-enhanced MRI to predict pathological complete response...
-
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer
PurposeWhile 18 F-FDG PET/CT (FDG-PET/CT) is consensual for clinical stage ≥ IIB breast cancers (BC), its benefit for stage I or IIA HER2+ or...
-
Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT
BackgroundAccurate diagnosis of axillary lymph node (ALN) metastases is essential for prognosis and treatment planning in breast cancer. Evaluation...
